Mitotic checkpoint defects: en route to cancer and drug resistance

Sinjini Sarkar1,2, Pranab Kumar Sahoo1, Sutapa Mahata1

  • 1Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata, West Bengal, 700026, India.

Insights

Mitotic checkpoint defects can lead to cancer and drug resistance, but recent findings question their direct role. Further research is exploring this pathway for improved cancer treatments.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Genetics

Background:

  • Malignant cells often exhibit dysregulated mitosis, leading to inaccurate chromosome segregation and aneuploidy.
  • The mitotic checkpoint ensures faithful chromosome transmission, and its defects are linked to cancer development and drug resistance.
  • Existing research presents contradictory findings regarding the direct role of mitotic checkpoint defects in carcinogenesis and drug resistance.

Purpose of the Study:

  • To discuss the role of faulty checkpoint signaling in cancer development.
  • To explore the contribution of mitotic checkpoint defects to drug resistance in cancer treatment.
  • To review the latest research on the mitotic checkpoint pathway for improved cancer therapies.

Main Methods:

  • Literature review and synthesis of existing research findings.
  • Analysis of studies investigating mitotic checkpoint function in cancer.
  • Examination of data on drug resistance mechanisms related to the mitotic checkpoint.

Main Results:

  • Defects in the mitotic checkpoint can result in aneuploidy, a hallmark of cancer.
  • Mitotic slippage and senescence, even with an active checkpoint, contribute to drug resistance.
  • Contradictory evidence necessitates a re-evaluation of the direct causal link between checkpoint defects and adverse outcomes.

Conclusions:

  • Faulty mitotic checkpoint signaling may contribute to cancer development and drug resistance, but its precise role is complex and debated.
  • Further investigation into the nuances of mitotic checkpoint function is crucial for understanding cancer progression.
  • Exploring novel therapeutic strategies targeting the mitotic checkpoint pathway holds promise for enhancing cancer treatment outcomes.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.9K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.2K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K